These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9860410)

  • 1. Acute effects of transjugular intrahepatic portosystemic stent-shunt (TIPSS) procedure on renal blood flow and cardiopulmonary hemodynamics in cirrhosis.
    Stanley AJ; Redhead DN; Bouchier IA; Hayes PC
    Am J Gastroenterol; 1998 Dec; 93(12):2463-8. PubMed ID: 9860410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and regional changes in plasma endothelin following transient increase in portal pressure.
    Kapoor D; Redhead DN; Hayes PC; Webb DJ; Jalan R
    Liver Transpl; 2003 Jan; 9(1):32-9. PubMed ID: 12514771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of transjugular intrahepatic portosystemic stent shunts on portal and systemic hemodynamics of patients with portal hypertension].
    Wu X; Li J; Cao J; Wu X; Ni X
    Zhonghua Wai Ke Za Zhi; 1998 Jun; 36(6):342-4. PubMed ID: 11825406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis.
    Lotterer E; Wengert A; Fleig WE
    Hepatology; 1999 Mar; 29(3):632-9. PubMed ID: 10051460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical results and hemodynamic changes of portal venous system in transjugular intrahepatic portosystemic stent shunt].
    Wu X; Cao J; Wu X
    Zhonghua Wai Ke Za Zhi; 1996 May; 34(5):303-6. PubMed ID: 9387710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function.
    Van der Linden P; Le Moine O; Ghysels M; Ortinez M; Devière J
    Hepatology; 1996 May; 23(5):982-7. PubMed ID: 8621179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute endotoxemia following transjugular intrahepatic stent-shunt insertion is associated with systemic and cerebral vasodilatation with increased whole body nitric oxide production in critically ill cirrhotic patients.
    Jalan R; Olde Damink SW; Ter Steege JC; Redhead DN; Lee A; Hayes PC; Deutz NE
    J Hepatol; 2011 Feb; 54(2):265-71. PubMed ID: 21067839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in liver perfusion caused by transjugular intrahepatic stent shunt (TIPSS)].
    Richter GM; Brado M; Simon C; Mädler U; Radeleff B; Roeren T; Sauer P; Kauffmann GW
    Zentralbl Chir; 1997; 122(2):108-16. PubMed ID: 9173754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt.
    Russo MW; Jacques PF; Mauro M; Odell P; Brown RS
    Liver Transpl; 2002 Mar; 8(3):271-7. PubMed ID: 11910573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents.
    Ockenga J; Kroencke TJ; Schuetz T; Plauth M; Kasim E; Petersein J; Schmidt HH; Lochs H
    Scand J Gastroenterol; 2004 Oct; 39(10):994-9. PubMed ID: 15513340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transjugular intrahepatic portosystemic shunt for liver transplantation.
    Zhou GW; Cai WY; Li HW; Zhu Y; Dodson F; Fung JJ
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):179-82. PubMed ID: 14607734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W; Liu P; Blendis L; Wong F
    Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt.
    Huonker M; Schumacher YO; Ochs A; Sorichter S; Keul J; Rössle M
    Gut; 1999 May; 44(5):743-8. PubMed ID: 10205217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct measurement of post-prandial portal haemodynamics in cirrhotic patients with a transjugular intrahepatic portosystemic stent-shunt.
    Stanley AJ; Forrest EH; Redhead DN; Bouchier IA; Hayes PC
    Eur J Gastroenterol Hepatol; 1998 May; 10(5):393-7. PubMed ID: 9619385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man?
    Jalan R; Forrest EH; Redhead DN; Dillon JF; Hayes PC
    Gut; 1997 May; 40(5):664-70. PubMed ID: 9203948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of liver function and portosystemic pressure gradient after TIPSS and late TIPSS occlusion.
    Maedler U; Hansmann J; Duex M; Noeldge G; Sauer P; Richter GM
    Cardiovasc Intervent Radiol; 2002; 25(2):148-51. PubMed ID: 11901436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic and splanchnic perfusion and oxygenation after transjugular intrahepatic portosystemic shunt.
    Cervera M; Añón R; Palmero J; Martínez J; Garcés R; Ripollés T; Moreno-Osset E; Alamán G; Antón M
    Rev Esp Enferm Dig; 2000 Apr; 92(4):199-210. PubMed ID: 10867409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience of transjugular intrahepatic portosystemic shunt (TIPS) and its effects on systemic hemodynamics.
    Naritaka Y; Ogawa K; Shimakawa T; Wagatsuma Y; Konno S; Katsube T; Hamaguchi K; Hosokawa T
    Hepatogastroenterology; 2004; 51(59):1470-2. PubMed ID: 15362779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt.
    Trebicka J; Krag A; Gansweid S; Appenrodt B; Schiedermaier P; Sauerbruch T; Spengler U
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1218-25. PubMed ID: 21971377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.